Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
miRNAをターゲットとした神経変性疾患の治療
Document Type and Number:
Japanese Patent JP5710001
Kind Code:
B2
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating neurodegenerative diseases by targeting a specific miRNA. In addition, the present invention relates to a kit for diagnosing neurodegenerative diseases. A miR-206 target found in the present invention, which is highly expressed in both animal models of Alzheimer's disease and human brain samples, is a substantial treatment target selected without artifact errors. An antisense oligonucleotide of the present invention as an inhibitor for miR-206 suggests a successful result in treatment of neurodegenerative diseases by targeting miRNA. The antisense oligonucleotide of the present invention inhibits the function of miR-206 to greatly increase the levels of BDNF and IGF-1 and to increase the regeneration of synapses, thereby treating neurodegenerative diseases, particularly Alzheimer's disease.

Inventors:
No Jaekyu
Lee Sang Khun
Kim Man Ho
Ju Kong
Jung Gun Hwa
Lee Sun Tae
Application Number:
JP2013529052A
Publication Date:
April 30, 2015
Filing Date:
September 09, 2011
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SNU R&DB FOUNDATION
International Classes:
A61K48/00; A61K31/7088; A61K31/712; A61P21/02; A61P25/28; C12Q1/68; G01N33/53
Domestic Patent References:
JP2009519339A
Foreign References:
WO2009026576A1
WO2007044937A1
WO2009117418A1
WO2008147974A1
Other References:
Hugon,J. et al,Targeting miRNAs in Alzheimer’s disease,Expert Review of Neurotherapeutics,2008年,Vol. 8, No. 11,pp. 1615-1616
RAU CHENG-SHYUAN et al,Entrapment neuropathy results in different microRNA expression patterns from denervation injury in rats,BMC MUSCULOSKELETAL DISORDERS,2010年,vol. 11, no. 1,pp. 181(1-9)
Attorney, Agent or Firm:
Koichi Hirota
Yoshihiro Nagare
Naoko Matsuda



 
Previous Patent: 物体検知装置

Next Patent: JPS5710002